rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Paul W. Hoelscher

Director

Company insider

Files Form 4 as: Director, Sagimet Biosciences; Director, OnKure Therapeutics; EVP, CFO, Horizon Therapeutics Public Ltd Co.

Every Form 4 they filed

In numbers

Trades disclosed
137
Buys
0
Sells
12
Bought
$0
Sold
$62.9M
Companies
3
Companies where not an officer
2
First trade
27 Jun 2014
Last trade
12 Jun 2026
Last filed
15 Jun 2026

Companies traded

Where they are an officer
Horizon Therapeutics Public Ltd CoOfficer · last 20 Apr 20220 buys · 12 sells
Everywhere else they filed: board seats, 10% stakes, other companies
SGMT Sagimet BiosciencesDirector · Biotechnology · last 12 Jun 20260 buys · 0 sells
OKUR OnKure TherapeuticsDirector · Biotechnology · last 6 Jun 20230 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
12 Jun 2026filed 15 Jun 2026SGMT Sagimet Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—39,567 at $0.00filing
12 Jun 2026filed 15 Jun 2026SGMT Sagimet Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—39,567 at $0.00filing
9 Jun 2025filed 10 Jun 2025SGMT Sagimet Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—32,250 at $0.00filing
5 Jun 2024filed 7 Jun 2024SGMT Sagimet Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—9,279 at $0.00filing
1 Apr 2024filed 3 Apr 2024SGMT Sagimet Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—73,014 at $0.00filing
6 Jun 2023filed 8 Jun 2023OKUR OnKure Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—17,500 at $0.00filing
1 Jun 2022filed 3 Jun 2022OKUR OnKure Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—6,376 at $0.00filing
20 Apr 2022filed 22 Apr 2022Horizon Therapeutics Public Ltd Cooption or derivativeSEC FORM 4 Code M—50,000 at $0.00filing
20 Apr 2022filed 22 Apr 2022Horizon Therapeutics Public Ltd CoSEC FORM 4 Code M$1.1M50,000 at $22.14filing
20 Apr 2022filed 22 Apr 2022Horizon Therapeutics Public Ltd CoSEC FORM 4 Sold$3.3M28,458 at $114.36filing
20 Apr 2022filed 22 Apr 2022Horizon Therapeutics Public Ltd CoSEC FORM 4 Sold$2.5M21,542 at $115.17filing
6 Apr 2022filed 8 Apr 2022Horizon Therapeutics Public Ltd Cooption or derivativeSEC FORM 4 Code M—30,275 at $0.00filing
6 Apr 2022filed 8 Apr 2022Horizon Therapeutics Public Ltd Cooption or derivativeSEC FORM 4 Code M—185,060 at $0.00filing
6 Apr 2022filed 8 Apr 2022Horizon Therapeutics Public Ltd CoSEC FORM 4 Code M$483K30,275 at $15.96filing
6 Apr 2022filed 8 Apr 2022Horizon Therapeutics Public Ltd CoSEC FORM 4 Code M$4.1M185,060 at $22.14filing
6 Apr 2022filed 8 Apr 2022Horizon Therapeutics Public Ltd CoSEC FORM 4 Sold$23.7M215,335 at $110.01filing
6 Apr 2022filed 8 Apr 2022Horizon Therapeutics Public Ltd CoSEC FORM 4 Sold$10.1M91,710 at $110.01filing
25 Mar 2022filed 25 Mar 2022Horizon Therapeutics Public Ltd CoSEC FORM 4 Sold$73K663 at $110.00filing
24 Mar 2022filed 25 Mar 2022Horizon Therapeutics Public Ltd CoSEC FORM 4 Sold$163K1,481 at $110.00filing
23 Mar 2022filed 25 Mar 2022Horizon Therapeutics Public Ltd Cooption or derivativeSEC FORM 4 Code M—26,090 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed12

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.